• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过粘膜途径进行病毒疫苗接种。

Viral vaccination via the mucosal routes.

作者信息

Ogra P L, Fishaut M, Gallagher M R

出版信息

Rev Infect Dis. 1980 May-Jun;2(3):352-69. doi: 10.1093/clinids/2.3.352.

DOI:10.1093/clinids/2.3.352
PMID:6997965
Abstract

Viral vaccines have been successfully administered by the mucosal route for two decades now. However, only in the last 10 years have the concepts involved in mucosal immunocompetence been well characterized. It is apparent that the bronchus-associated lymphoid tissue, the gut-associated lymphoid tissue, and the immunocompetent cells present in ocular tissue, conjunctiva, nasopharynx, genital tract, and secretions of the mammary glands represent the components of the common mucosal immune system. The predominant immunologic activity in the external mucosal surfaces is associated with secretory IgA and T lymphocytes, with variable contributions from other immunoglobulins and macrophages. Evidence presented in this review suggests that immunization via the mucosal routes of the respiratory and gastrointestinal tracts is the most effective means of inducing effective immunity in the mucosal surfaces as well as in the systemic tissues. Available experience with mucosal immunization with poliovirus, rubella virus, measles virus, and adenovirus vaccines in humans and with other viral vaccines in animals is briefly reviewed.

摘要

二十年来,病毒疫苗已成功通过黏膜途径接种。然而,直到最近十年,黏膜免疫能力所涉及的概念才得到充分表征。显然,支气管相关淋巴组织、肠道相关淋巴组织以及眼组织、结膜、鼻咽、生殖道和乳腺分泌物中存在的免疫活性细胞代表了共同黏膜免疫系统的组成部分。外部黏膜表面的主要免疫活性与分泌型IgA和T淋巴细胞有关,其他免疫球蛋白和巨噬细胞也有不同程度的贡献。本综述提供的证据表明,通过呼吸道和胃肠道的黏膜途径进行免疫接种是在黏膜表面以及全身组织中诱导有效免疫的最有效手段。本文简要回顾了人类使用脊髓灰质炎病毒、风疹病毒、麻疹病毒和腺病毒疫苗以及动物使用其他病毒疫苗进行黏膜免疫的现有经验。

相似文献

1
Viral vaccination via the mucosal routes.通过粘膜途径进行病毒疫苗接种。
Rev Infect Dis. 1980 May-Jun;2(3):352-69. doi: 10.1093/clinids/2.3.352.
2
Immunologic and virologic aspects of secretory immune system in human respiratory tract.人类呼吸道分泌免疫系统的免疫学和病毒学方面
Dev Biol Stand. 1975;28:129-44.
3
Mucosal responses to parenteral and mucosal vaccines.对肠胃外和粘膜疫苗的粘膜反应。
Dev Biol Stand. 1998;95:141-6.
4
Mucosal immune response to poliovirus vaccines in childhood.
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S361-8. doi: 10.1093/clinids/6.supplement_2.s361.
5
Mucosal immunity: implications for vaccine development.黏膜免疫:对疫苗研发的启示
Immunobiology. 1992 Feb;184(2-3):157-79. doi: 10.1016/S0171-2985(11)80473-0.
6
New recommendations for simultaneous administration of live virus vaccines.
J Iowa Med Soc. 1973 Feb;63(2):50 passim.
7
Intranasal and sublingual delivery of inactivated polio vaccine.灭活脊髓灰质炎疫苗的鼻内和舌下给药
Vaccine. 2017 May 9;35(20):2647-2653. doi: 10.1016/j.vaccine.2017.03.090. Epub 2017 Apr 8.
8
Mucosal immune system: implications in otitis media with effusion.黏膜免疫系统:在分泌性中耳炎中的意义
Ann Otol Rhinol Laryngol Suppl. 1980 May-Jun;89(3 Pt 2):326-32. doi: 10.1177/00034894800890s378.
9
Immunizations: current controversies.免疫接种:当前的争议
J Pediatr. 1982 Oct;101(4):487-94. doi: 10.1016/s0022-3476(82)80686-0.
10
Prospects for human mucosal vaccines.人类黏膜疫苗的前景。
Adv Exp Med Biol. 1992;327:13-23. doi: 10.1007/978-1-4615-3410-5_3.

引用本文的文献

1
Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Infections: A Review of Epidemiology and Progress in Detection and Management.免疫缺陷相关疫苗衍生脊髓灰质炎病毒(iVDPV)感染:流行病学及检测与管理进展综述
Pathogens. 2024 Dec 20;13(12):1128. doi: 10.3390/pathogens13121128.
2
Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination.灭活脊髓灰质炎病毒疫苗加强针可降低口服脊髓灰质炎疫苗初免个体出现新冠病毒感染相关结果的可能性。
Vaccines (Basel). 2024 Feb 20;12(3):219. doi: 10.3390/vaccines12030219.
3
[Increasing the efficiency of a mobile EPI strategy using injectable polio vaccine in Africa].
[在非洲使用注射用脊髓灰质炎疫苗提高流动扩大免疫规划策略的效率]
Med Trop Sante Int. 2023 Jun 2;3(2). doi: 10.48327/mtsi.v3i2.2023.344. eCollection 2023 Jun 30.
4
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial.新型口服脊髓灰质炎病毒 2 型疫苗与二价口服脊髓灰质炎病毒疫苗同时接种的免疫原性:一项开放标签、非劣效性、随机、对照试验。
Lancet Infect Dis. 2023 Sep;23(9):1062-1071. doi: 10.1016/S1473-3099(23)00139-1. Epub 2023 May 10.
5
Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks.使用灭活脊灰病毒疫苗控制 2 型循环疫苗衍生脊灰病毒 (cVDPV) 暴发的活动中的使用情况综述。
Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A113-A121. doi: 10.1016/j.vaccine.2022.03.027. Epub 2022 Mar 29.
6
Mucosal immunity and the eradication of polio.黏膜免疫与脊髓灰质炎的根除
Science. 2020 Apr 24;368(6489):362-363. doi: 10.1126/science.abb8588.
7
[Immunity and antiviral vaccinations. Example: the respiratory mucosa].[免疫与抗病毒疫苗接种。示例:呼吸道黏膜]
Antibiotiques (Paris). 2007 May;9(2):130-138. doi: 10.1016/S1294-5501(07)88778-4. Epub 2008 Jan 3.
8
Current state and challenges in developing oral vaccines.口服疫苗研发的现状与挑战
Adv Drug Deliv Rev. 2017 May 15;114:116-131. doi: 10.1016/j.addr.2017.04.008. Epub 2017 Apr 22.
9
Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule.经无线电控制胶囊口服腺病毒传递流感疫苗至人体肠道后的系统性和黏膜免疫应答。
Sci Rep. 2016 Nov 24;6:37295. doi: 10.1038/srep37295.
10
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.脊髓灰质炎病毒免疫和传播的回顾与评估:知识空白的综合分析与研究需求的确定。
Risk Anal. 2013 Apr;33(4):606-46. doi: 10.1111/risa.12031. Epub 2013 Mar 28.